Navigation Links
Amorcyte, a NeoStem Company, Enrolls First Patient in PreSERVE Phase 2 Trial for Acute Myocardial Infarction
Date:1/25/2012

biological mechanism of action that the outcomes of the current study are intended to demonstrate.  The Amorcyte therapy is being developed initially for the preservation of heart muscle function for approximately 160,000 American patients who sustain a heart muscle damaging STEMI annually.

Dr. Pecora further added, "Even with current best clinical practices, this group faces a significant chance of adverse outcomes, including premature death.  Our goal is to create significant pharmacoeconomic value by reducing the associated costs of adverse outcomes often seen in these patients. We feel AMR-001 has the potential to address a substantial unmet medical need."

For more information on the clinical trial please visit www.amorcyte.com or view the NeoStem corporate presentation at www.neostem.com/investor-relations/.

About NeoStem, Inc. and Amorcyte, LLC, a NeoStem companyNeoStem, Inc. ("NeoStem") is a leader in the development and manufacture of cell therapies. NeoStem has a strategic combination of revenues, including that which is derived from the contract manufacturing services performed by Progenitor Cell Therapy, LLC, a NeoStem company. That manufacturing base is one of the few cGMP facilities available for contracting in the burgeoning cell therapy industry, and it is the combination of PCT's core expertise in manufacturing and NeoStem's extensive research capabilities that positions the company as a leader in cell therapy development. Amorcyte, LLC, also a NeoStem company, is developing a cell therapy for the treatment of cardiovascular disease. Amorcyte's lead compound, AMR 001, represents NeoStem's most clinically advanced therapeutic and is open for enrollment in a Phase 2 trial for the preservation of heart muscle function after a heart attack.  Amorcyte expects to begin a Phase 1 clinical trial in 2012 for AMR-001 for
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NeoStem Appoints a Biopharmaceutical Business Leader and a Cellular Therapy Expert to its Board of Directors
2. NeoStem Provides Updates, Reports Results for Third Quarter and Upcoming November Company Presentations
3. NeoStem Announces Change in Presentation Time for JMP Securities Conference
4. NeoStem Announces Participation in Multiple September Conferences
5. NeoStem Appoints Grant Thornton LLP as New Independent Registered Public Accounting Firm
6. NeoStem Provides Update on Amorcyte Clinical Progress and Reports Results for Second Quarter
7. NeoStem Announces Pricing of Public Offering for $16,500,000 in Gross Proceeds
8. NeoStem Announces Proposed Public Offering of Common Stock
9. NeoStem Signs Definitive Merger Agreement to Acquire Amorcyte in Equity Transaction
10. NeoStem Announces Agreement with Nankai Hospital in Tianjin to Offer NeoStems Licensed Orthopedic Technology
11. NeoStems Suzhou Erye Pharmaceutical Receives Two Awards at the Chempharm Brand Summit 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... China, Sept. 2, 2015 China Nepstar Chain ... "Company"), a leading retail drugstore chain in China based ... its unaudited financial results for the second quarter ended ... ended June 30, 2015: , Revenue increased by ... million in the second quarter of 2014 , ...
(Date:9/1/2015)... On August 31, 2015, United States District ... 123-page order in the first of the consolidated MDL ... replacement devices are defective.[1]  The Court ... Robyn Christiansen,s claims for defective design, fraudulent misrepresentation and ... Medical,s claim that the Medical Device Amendment to the ...
(Date:9/1/2015)... Va. , Sept. 1, 2015  AccuTec Blades, ... Company,s (EPC) Industrial Blades division.  EPC announced in May ... in Verona, Virginia and ... completion of the sale process. ... Officer of AccuTec Blades said, "Our new name, AccuTec ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 10Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 2Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 3AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2
(Date:9/2/2015)... ... ... A recent survey by Consumer Reports ( http://bit.ly/1h67tL8 ) sheds light on the ... It was reported that 33% are paying an average of $39 more out-of-pocket for ... compared to last year. Among the drugs that saw the highest increases were those ...
(Date:9/2/2015)... ... 02, 2015 , ... EDAC Systems, Inc., a leading value-added ... services to both government and commercial clients, today announced the release of a ... Datacap document capture platform. EDAC PurePAGE processes and enhances the images whether ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... PHYTOMER, the pioneer in marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich ... new cream combines breakthrough biotechnological anti-aging power with a lipid-replenishing marine oil for ...
(Date:9/2/2015)... ... 02, 2015 , ... Dr. Robert G. Schwartz , the principal of ... “Systema”: a Russian martial art system that is also a philosophy of life that ... which dates back to the 10th century, is a Russian Martial Art that has ...
(Date:9/1/2015)... ... September 01, 2015 , ... An August ... thousands of plastic surgeries conducted each year on teenagers, quoting a New York ... numbers. Beverly Hills-based plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known more familiarly ...
Breaking Medicine News(10 mins):Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Dr. Robert G. Schwartz Achieves Certification in Russian Martial Art “Systema” and Focuses on Integrating Techniques & Principles into Health Care Delivery 2Health News:Dr. Robert G. Schwartz Achieves Certification in Russian Martial Art “Systema” and Focuses on Integrating Techniques & Principles into Health Care Delivery 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2
... recent study at the University of North Carolina in Chapel ... the National Cancer Institute suggests that two genes - C282Y ... hemochromatosis may also lead to an increased risk of developing ... 1,300 subjects were studied, out// of which, more than 400 ...
... A new study by researchers in Charleston has ... depressive disorder in individuals with diabetes. For the ... Health Interview Survey, which was used to evaluate ... researchers found that depressed individuals with diabetes, were ...
... the Johns Hopkins University School of Medicine in Baltimore cautioned ... screening for lung cancer. They claimed that the harm of ... that turn out to be benign,// and the costs of ... annual full-body CT screening. ,Following this, the National Cancer ...
... University in Boston has revealed that children as young as ... They also use emotional information picked up from adults around ... psychology at Tufts University, and her team tested //babies, showing ... red spiral letter holder, a blue bumpy ball, and a ...
... found that continuous combined hormone therapy(estrogen combined with 25 ... associated with an increased breast cancer risk among current ... for five or more years. The study however did ... hormone therapy and breast cancer risk. This indicated that ...
... by removing a disc or placing a bone graft in ... disc which is being studied as a replacement is in ... was recently completed compared the prosthesis to traditional fusion. While ... one having a fusion operation for every two that received ...
Cached Medicine News:Health News:Artificial discs available as replacements for damaged discs 2
... The VersaPulse PowerSuite holmium laser ... properties for precise, virtually bloodless procedures. ... fragmenting urinary and gall bladder stones ... ideal multipurpose surgical tool. Because its ...
... Nd:YAG technology has allowed for perfecting mini-invasive ... of various pathologies with a considerable social ... for reducing the post-operatory times and represents ... costs in all hospital structures.,DEKAs family of ...
... have to choose. The Apogee Elite ... 755nm Alexandrite laser and a high ... in one convenient unit. The ... for hair removal, pigmented lesions, facial ...
Single use trocar with non-conductive sleeves for gaining and maintaining thoracic access., ,THORACOPORT™ devices are trocars used to gain access to the thoracic cavity for use in video assis...
Medicine Products: